Exploring community factors affecting opioid use disorder and treatment adherence
Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy
['FUNDING_CAREER'] · GEISINGER CLINIC · NIH-10864937
This study is looking at how different community and program factors affect the risk of opioid use disorder and how well medication-assisted treatment works, with the goal of finding ways to help people stick with their treatment and improve their recovery.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEISINGER CLINIC (nih funded) |
| Locations | 1 site (DANVILLE, UNITED STATES) |
| Trial ID | NIH-10864937 on ClinicalTrials.gov |
What this research studies
This research investigates how various community and program factors influence the risk of opioid use disorder (OUD) and the effectiveness of medication-assisted treatment (MAT). It aims to identify barriers to long-term treatment adherence and develop strategies to enhance patient retention in MAT programs. The project will utilize electronic health record data to conduct a two-phase epidemiologic study, providing insights that could improve treatment outcomes for individuals struggling with OUD. The research is supported by a team of experienced mentors and aims to equip the principal investigator with the skills needed for independent research.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 21 and older who are receiving or are eligible for medication-assisted treatment for opioid use disorder.
Not a fit: Patients who are not currently engaged in treatment for opioid use disorder or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment adherence for patients with opioid use disorder, ultimately enhancing their recovery outcomes.
How similar studies have performed: Previous research has shown success in using community and programmatic factors to improve treatment adherence in similar populations, indicating that this approach has potential.
Where this research is happening
DANVILLE, UNITED STATES
- GEISINGER CLINIC — DANVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: POULSEN, MELISSA — GEISINGER CLINIC
- Study coordinator: POULSEN, MELISSA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.